[Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Xuejuan Wang(Shenyang Institute of Automation), Meiying Zhang(Fujian Medical University), Tao Ouyang(Peking University), Bing Xu(Fujian Medical University), Yan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Baohe Lin, Jinfeng Li(Hebei Medical University), Zhi Yang(Peking University)
PubMed
March 1, 2006
Cited by 6
Related Papers
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
|Journal of Ovarian Research|2014|545
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218